…software, the package provides layered insight into multiple analytes across all blood cancers, reducing drug development time and cost by at least half. The company has parterned with BioLegend, provider…

…clinical trial process lasts between 7.5 and 12 years with costs ranging from $161M – $2.6B per drug. Yet in spite of this investment, the success rate of clinical trials…

…antibodies with the greatest potential. Dr Jane Osbourn OBE, CSO at Alchemab and leader of the Taskforce, said: “We have accelerated the standard timelines for antibody discovery, taking 7 months…

…to show the use of a novel drug that inhibits the effects of RAS genes in multiple places. The researchers said the drug should now be tested in larger trials,…

…of Project Strategy at TherapeutAix, said: “One of the biggest challenges in drug discovery and development is understanding the bioavailability of a compound or drug and how it will behave…

The 3D cell culture company, CN Bio, has launched Drug Metabolism and Safety Toxicity Testing Services. Liver toxicity is a principal safety concern during drug discovery and development, with the…

…future growth and bridge the gap between discovery and industrialisation, the Testa Center was established in 2018 by the Swedish government and Cytiva. Located on Cytiva’s site the 2500 m2…

…grown in cell culture. Importantly, by using monoclonal antibodies – lab-created proteins that resemble naturally occurring antibodies – or a selective drug that blocks the interaction we have been able…

…United States Food and Drug Administration (US FDA) and the Engineering and Physical Sciences Research Council (EPSRC). Preprint paper ‘SARS-CoV-2 candidate vaccine ChAdOx1 nCoV-19 infection of human cell lines reveals…

The Food and Drug Administration (FDA) has today authorised a restart of clinical trials of the ChAdOx1 nCov-2019 Oxford coronavirus vaccine in the USA following the trials restarting in the…